For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit

You are here


Found 775 results
Author Title Type [ Year(Desc)]
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Schirmer F, Ehrt S, Hillen W.  1997.  Expression, inducer spectrum, domain structure, and function of MopR, the regulator of phenol degradation in Acinetobacter calcoaceticus NCIB8250.. J Bacteriol. 179(4):1329-36.
Ma X, Neurath M, Gri G, Trinchieri G.  1997.  Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter.. J Biol Chem. 272(16):10389-95.
Lue NF, Peng Y.  1997.  Identification and characterization of a telomerase activity from Schizosaccharomyces pombe.. Nucleic Acids Res. 25(21):4331-7.
MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan C.  1997.  Identification of nitric oxide synthase as a protective locus against tuberculosis.. Proc Natl Acad Sci U S A. 94(10):5243-8.
Ma X, Aste-Amezaga M, Gri G, Gerosa F, Trinchieri G.  1997.  Immunomodulatory functions and molecular regulation of IL-12.. Chem Immunol. 68:1-22.
Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Trinchieri G, Karp CL.  1997.  Inhibition of human interleukin-12 production by pentoxifylline.. Immunology. 91(2):197-203.
Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Flockhart DA, Trinchieri G, Karp CL.  1997.  Inhibition of IL-12 production by thalidomide.. J Immunol. 159(10):5157-61.
Worgall S, Wolff G, Falck-Pedersen E, Crystal RG.  1997.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.. Hum Gene Ther. 8(1):37-44.
Ferguson DO, Rice MC, Rendi MH, Kotani H, Kmiec EB, Holloman WK.  1997.  Interaction between Ustilago maydis REC2 and RAD51 genes in DNA repair and mitotic recombination.. Genetics. 145(2):243-51.
Sartori A, Ma X, Gri G, Showe L, Benjamin D, Trinchieri G.  1997.  Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells.. Methods. 11(1):116-27.
Onel K, Holloman WK.  1997.  Molecular cloning of a gene required for DNA replication in Ustilago maydis.. Mol Gen Genet. 253(4):463-8.
Ehrt S, Shiloh MU, Ruan J, Choi M, Gunzburg S, Nathan C, Xie Q, Riley LW.  1997.  A novel antioxidant gene from Mycobacterium tuberculosis.. J Exp Med. 186(11):1885-96.
Maxfield LF, Spector DJ.  1997.  Readthrough activation of early adenovirus E1b gene transcription.. J Virol. 71(11):8321-9.
Berens C, Schnappinger D, Hillen W.  1997.  The role of the variable region in Tet repressor for inducibility by tetracycline.. J Biol Chem. 272(11):6936-42.
Prescott JC, Liu L, Falck-Pedersen E.  1997.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.. Mol Cell Biol. 17(4):2207-16.
Deitsch KW, Moxon ER, Wellems TE.  1997.  Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections.. Microbiol Mol Biol Rev. 61(3):281-93.